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Summary
Signaling by D 2 -dopamine receptors in neurons likely proceeds in the presence of Ca DARPP-32, an inhibitor of protein phosphatase 1. DARPP-32 is dephosphorylated on D 2 -dopamine receptor activation and thus becomes active; this effect is strongly enhanced by Ca 2+ /CaM through activation of calcineurin (9) . These examples suggest that the signal transduced by Ca 2+ /CaM and signaling initiated by the intracellular D 2 -receptor overlap and may add to each other.
We have found in the primary peptide sequence of the human D 2 -dopamine receptor a CaMbinding motif which is located in the N-terminus of the third cytoplasmic loop of the receptor.
In the present work we report that CaM can convey a Ca 2+ -signal directly to the receptor through binding to this receptor domain. When Ca 2+ /CaM binds to the receptor, it antagonizes signaling by the receptor at the level of receptor-mediated G protein turnover. Based on these observations, we propose to extend the concept of a cross-talk between CaM activation and D 2 -receptor signaling; by binding to the receptor CaM exerts feed-back inhibition to downtone the signaling efficiency of the D 2 -receptor. In the presence of repetitive Ca 2+ oscillations,
i.e. when the neuron is actively firing action potentials, CaM is suggested to suppress overt enhancement of dopamine receptor signal transduction in striatal nerve cells. 
Experimental Procedures

Materials
Determination of cAMP formation
HEK293 cells were grown to confluence in 6-well plates. The adenine nucleotide pool was labeled by incubating the cells for 16 h with [ 3 H]adenine (2 µCi/well). After that the medium was replaced and the cells were pre-incubated for 1h with 100 µM of the phosphodiesterase inhibitor rolipram. The production of cAMP was stimulated by the addition of 25 µM forskolin; receptor-mediated inhibition of cAMP formation was assessed in the absence and presence of the Ca 2+ -ionophore A23187 (calcimycin) at a concentration of 3 µM (Ca 2+ con-Recombinant, myristoylated Gα i-1 was produced in Escherichia coli and purified from bacterial lysates as described in (14) .
Radioligand binding experiments
Receptor-promoted G protein activation was determined by measuring the association rate of 22°C the CaM-sepharose was washed three times with 100 µl buffer each and finally resuspended in 100 µl of SDS-sample buffer; 30 µl aliquots were boiled and separated on an SDSpolyacrylamide gel. The proteins were transferred to a nitrocellulose membrane and the blot was probed with a Gα i-1 specific antiserum (I1C, directed against the residues 160-169 of Gα i-1 , 16). The immunoreactive bands were visualized by enhanced chemiluminiscence using horseradish peroxidase-conjugated anti-rabbit immunoglobulin.
Fluorescence measurements
The interaction between D2N and dansyl-CaM were examined by measuring peptide-induced changes in the fluorescence intensity of dansyl-CaM on excitation with UV-light at a wavelength of 340 nm. The fluorescence emission spectrum of dansyl-CaM was recorded using a Hitachi F-4500 fluorescence spectrophotometer in a cuvette at a volume of 0.24 ml. 
Detection of receptor peptide-CaM complexes
Binding of D2N to CaM was examined by cross-linking. CaM (6.6 µM) and D2N (3 µM) were incubated in 50 mM Hepes.NaOH buffer (pH = 
Immunoprecipitation of the epitope-tagged D 2 -dopamine receptor
Membranes prepared from the cells stably expressing c-myc-D 2 R were washed with EGTA as described above; subsequently the membranes (2 mg) were solubilized with 0.6 % cholate (the ratio of detergent to membrane protein was 3:1) in HME buffer containing 750 mM NaCl and protease inhibitors (Pefabloc, Boehringer Mannheim). The insoluble material was collected by centrifugation at 35.000*g for 20 min. The supernatant was concentrated over a porous polycarbonate membrane (Amicon, cut off size = 30kDa) and subsequently, 0.1% digitonin was added, the concentration of cholate adjusted to 0.12% and the concentration of NaCl to and were applied to a SDS-polyacrylamide gel containing 6 M urea. The supernatant, the last out of three washes and the immunoprecipitate were analyzed. The c-myc-tagged D 2 R was detected by immunoblotting using a polyclonal antiserum directed against c-myc; in addition, the blot was probed with a G protein β-subunit-specific rabbit antiserum (17). Alternatively, the immunoprecipitate that had been prepared as described above was resuspended and gently Matched amounts of receptor (~ 0.3 pmol) were solubilized with 0.6% cholate in HME buffer containing 750 mM NaCl and 1 mM PMSF at 4°C for 60 min (detergent: protein = 3 : 1). This mixture was then centrifuged at 35.000*g for 20 min; 0.1% digitonin and 2 mM CaCl 2 were added to the supernatant and the concentration of cholate and of NaCl was adjusted to 0.06% and 150 mM, respectively. Of this an aliquot was removed and kept at 4°C. The solubilized receptors were then incubated with CaM immobilized on a sepharose matrix (packed matrix = 1/10 of the volume of the soluble extract) which had been equilibrated in matrix-buffer (HME, 0.06% cholate, 0.1% digitonin, 150 mM NaCl, 2 mM CaCl 2 ) for 2 h at 4°C.
Subsequently the CaM-sepharose was washed three times in 200 µl matrix-buffer and bound obtained values amounted to 5-15% of the values for receptor-bound radioactivity from which they were subtracted. In order to control for ligand dissociation from the solubilized receptors the decrease in binding was quantified for each of the time points at which a wash or elution step was performed. At 4°C the recovery of labeled D 2 -receptors was 98% and 85% after 15 min and 20 minutes, respectively. In the case of the A 1 -adenosine receptor, the recovery amounted to 70% and 56 % at the respective intervals. The values obtained were used to correct for the proportion of radioligand that dissociated during the wash and elution procedure.
A soluble extract was also prepared from COS-7 cell membranes expressing the HA-tagged D 2 -dopamine receptor (0.14 mg containing about 0.12 pmol receptors) and was incubated with equilibrated CaM-sepharose (150 µl packed matrix) under the conditions described above for 2 h. Thereafter, the CaM-sepharose was washed with 750 µl matrix buffer and finally taken up in 150 µl SDS-sample buffer. An aliquot was electrophoretically resolved and immunoblotted using a monoclonal anti-HA antibody (clone 16B12).
Results
The Ca
2+ -ionophore calcimycin impedes the inhibition of cAMP production mediated by the D 2 -dopamine receptor in HEK293 cells
The D 2 -dopamine receptor couples to G proteins of the G i/o subfamily and mediates inhibition of adenylyl cyclase. In HEK293 cells stably transfected with the human D 2 -receptor, quinpirol completely inhibited forskolin-stimulated cAMP formation (Fig. 1A) . If the cells were incubated with the Ca 2+ -ionophore calcimycin (3 µM), the inhibition elicited by quinpirol was attenuated; quinpirol failed to completely reverse the forskolin-induced cAMP production and the concentration-response curve shifted to higher agonist concentrations. The calcimycin effect on adenylyl cyclase inhibition was not seen in HEK293 cells expressing a different G i/o coupled receptor, the melatonin Mel 1a receptor (Fig. 1B) . In all cell lines, stimulation by forskolin was moderately decreased (to ~75%) by calcimycin.
Calmodulin blocks G protein activation by the D 2 -dopamine receptor
The data shown in Fig. 1 Formation of a single peptide-CaM complex was confirmed on a nondenaturing gel when
CaM was applied together with D2N in the presence of Ca 2+ (Fig. 3C ) In order to define the extent of the CaM-docking site we have also used two other 19-amino acid peptides derived from the same receptor domain but with their peptide sequences shifted 6 (D2N') and 9
(D2N'') amino acids toward the C-terminus. As opposed to D2N both control peptides which lack the first amino acids of the CaM-binding motif entirely failed to combine with Ca 2+ /CaM, underlining the importance of the motif-flanking residues.
Binding affinity of Ca
2+ /CaM for D2N
Because it is difficult to obtain reliable affinity estimates in cross-linking experiments, we determined the affinity of CaM for the D2N peptide by recording the changes in fluorescence emission of dansyl-CaM. The conformational change associated with binding of a ligand to
CaM causes an enhancement in fluorescence emission. In addition, the emission peak is blueshifted to a lower wavelength. This is illustrated by the original tracings shown in Fig. 4A . In at various concentrations of dansyl-CaM fell onto a straight line with a slope that was reasonably close to 1 (Fig. 4C) . The true affinity was approximated by extrapolating to infinitely low concentrations of dansyl-CaM, i.e. to the y-axis intercept. This calculation gave a K D of 80 nM, a value similar to the IC 50 for CaM observed in membranes (see Fig. 2C ). In the absence of Ca 2+ , addition of D2N also induced an increment in the fluorescence of dansylCaM; however, the affinity was substantially lower than in the presence of Ca 2+ (Fig. 2C, ❍) .
Calmodulin inhibits the activation of Gα i-1 by D2N
Neither Ca 2+ nor Ca 2+ /CaM had any appreciable effect on the rate of GTPγS-binding to purified (recombinant) Gα i-1 (Fig. 5A ), a reaction limited by the release of prebound GDP. (Fig. 5B, q) (Fig. 5D) . In contrast to the marked inhibition of G protein activation (see Fig. 2 ), CaM only very modestly reduced the number (but not the affinity) of high-affinity agonist binding sites. Thus, CaM did not interfere with the ability of the agonist-liganded receptor to form a complex with its cognate G protein(s) but selectively blocked the subsequent reaction step in signal transduction, i.e. the G protein turnover catalyzed by the active receptor.
Co-immunoprecipitation of the epitope tagged D 2 -dopamine receptor and CaM
In order to demonstrate a physical interaction of the D 2 -receptor with CaM we tagged the Nterminus with the c-myc epitope and expressed the epitope-tagged receptor in HEK293 cells.
EGTA-pretreated membranes were solubilized and the receptor was immunoprecipitated with a monoclonal antibody directed against the c-myc epitope. As a control we solubilized membranes from non-transfected cells and subjected the extract -in parallel -to the immuno- (Fig. 6C) . For illustrative purposes we depicted the last wash step; thereafter, the addition of EGTA released 10 and 25% of the radiolabeled D 2 -receptors added to CaMagarose and CaM-sepharose, respectively.
Binding of the solubilized D 2 -dopamine receptor to immobilized CaM
Thus, on CaM-sepharose -more than on CaM-agarose -a significant amount of radioactivity remained bound even after chelation of free Ca 2+ . This radioactivity was released by boiling in SDS and nominally amounted to ~15% of the total receptor-bound radioactivity (Fig. 6C) .
In order to prove that this fraction was liganded to the receptor, we chose two approaches.
First, we determined the non-specific binding of [matched amount of radioactivity; this non-specific binding was negligible. As a control, the same experiment was also performed with the A 1 -adenosine receptor expressed in HEK293 cells where similar amounts of the ligand [ 3 H]DPCPX were retained on the CaM-sepharose in the absence or presence of the receptors (1.0% vs.1.2% of total, not shown). This confirms that binding of CaM is a property specific to the D 2 -receptor which is not shared by the A 1 -adenosine receptor. Secondly, the CaM-sepharose was loaded with an epitope-tagged D 2 -receptor. After carrying out the wash steps, receptor-specific immunoreactivity was recovered by boiling the matrix in SDS (inset in Fig. 6C ). We stress that the immune reactive bands were probed with an anti-HA antiserum and that the HA-tagged receptor had been transiently expressed in COS-7 cells. Thus, immunoprecipitation (Fig. 6A) as well as immobilization on CaM-sepharose (Fig. 6C, inset ) yielded similar migration patterns of the D 2 -dopamine receptor and these were independent of the epitope-tag and of the cellular source.
Discussion
In the present work, we show that Ca In the tertiary structure of the membrane-bound receptor, the CaM interaction site is located adjacent to (the putative) transmembrane domain 5, removed by only two peptide bonds. We have also used as a control the peptides D2N' and D2N'', the sequences of which have been shifted toward the C-terminus of the 3 rd loop thereby curtailing the putative CaM-binding motif by 4 and 7 N-terminal residues, respectively. From these peptides it is evident that the motif has to be completely represented (i.e. including the flanking N-terminal residues) for CaM binding; the control peptides do not bind to Ca 2+ /CaM (Fig. 3C ) and do not activate G i either (not shown). Thus, functionally important residues are found in the 3 rd cytoplasmic loop/α-helix-boundary and this is also true for many other receptors (27) . The current view holds that receptor activation results in an enhanced tertiary interaction of these cue residues (28, 29) . This conformational change activates the cognate G protein and may similarly facilitate the docking of CaM which makes it a ligand-regulated process. 
